AJP - Regu AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R130-R143, 2002. First published February 28, 2002; doi:10.1152/ajpregu.00704.2001
0363-6119/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/R130    most recent
00704.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giardina, J. B.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giardina, J. B.
Right arrow Articles by Khalil, R. A.
Vol. 283, Issue 1, R130-R143, July 2002

TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats

Jena B. Giardina, Gachavis M. Green, Kathy L. Cockrell, Joey P. Granger, and Raouf A. Khalil

Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Tumor necrosis factor-alpha (TNF-alpha ) is elevated in the plasma of preeclamptic women and may have a role in pregnancy-induced hypertension. However, whether the hemodynamic effects of TNF-alpha reflect the direct effects on vascular reactivity is unclear. We tested the hypothesis that TNF-alpha impairs endothelium-dependent relaxation and enhances vascular contraction in systemic vessels of pregnant rats. We measured isometric contraction in aortic strips isolated from virgin and pregnant Sprague-Dawley rats (nontreated vs. treated for 2 h with 10-1,000 pg/ml TNF-alpha ). In endothelium-intact vascular strips, TNF-alpha caused greater enhancement of phenylephrine (Phe) contraction in pregnant than virgin rats. TNF-alpha caused significant inhibition of ACh- and bradykinin-induced vascular relaxation and nitrite/nitrate production that were more prominent in pregnant than virgin rats. NG-nitro-L-arginine methyl ester [L-NAME, 100 µM, an inhibitor of nitric oxide (NO) synthase] or 1H-[1,2,4]oxadiazolo[4,3]-quinoxalin-1-one (ODQ, 1 µM, an inhibitor of cGMP production in smooth muscle) inhibited ACh relaxation and enhanced Phe contraction in nontreated but to a lesser extent in TNF-alpha -treated vessels, particularly those of pregnant rats. Endothelium removal enhanced Phe contraction in nontreated but not TNF-alpha -treated vessels, especially those of pregnant rats. Relaxation of Phe contraction with the NO donor sodium nitroprusside was not different between nontreated and TNF-alpha -treated vessels. Thus TNF-alpha enhances vascular contraction and inhibits endothelium-dependent NO-cGMP-mediated vascular relaxation in systemic vessels, particularly those of pregnant rats. The results support a direct role for TNF-alpha as a possible mediator of increased vascular resistance associated with pregnancy-induced hypertension.

cytokines; endothelium; nitric oxide; pregnancy; arterial pressure; tumor necrosis factor-alpha


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

NORMAL PREGNANCY IS OFTEN associated with decreased systemic vascular resistance and arterial pressure and reduced vascular reactivity to circulating vasoconstrictors (20, 35, 46, 51). The hemodynamic and vascular changes associated with normal pregnancy have been attributed in part to increased nitric oxide (NO) synthesis by various cells including the vascular endothelial cells (1, 18, 54, 62, 69). This is supported by studies showing that the tissue expression and activity of NO synthase (NOS) are enhanced during late gestation (4, 13, 61, 68) and that the metabolic production and plasma level of guanosine 3',5'-cyclic monophosphate (cGMP), a second messenger of NO and a cellular mediator of vascular smooth muscle relaxation (30, 34), are increased during pregnancy (15).

In 5-10% of pregnancies, women develop a condition called preeclampsia, which is characterized by proteinuria, increased intravascular coagulation and systemic vascular resistance, and pregnancy-induced hypertension (PIH) (24, 49). Although PIH is a major cause of maternal and fetal morbidity and mortality, the mechanisms of this disorder have not been clearly identified. Studies in animal models of PIH have proposed that a localized reduction in the uteroplacental perfusion pressure and the ensuing placental ischemia and hypoxia during late pregnancy trigger the release of vasoactive factors from the ischemic placenta into the systemic circulation, and that the released factors in turn cause systemic vascular changes and lead to increased vascular resistance and PIH (3, 7, 11-17, 21, 35, 41, 47). Although several placental factors have been suggested, a key role for plasma cytokines in the pathogenesis of PIH has been hypothesized (12, 14, 39, 66). In support of the "cytokine hypothesis," it has been shown that the plasma levels of tumor necrosis factor-alpha (TNF-alpha ) are elevated in women with preeclampsia (14, 39, 66). Also, we have shown that a two- to threefold elevation in plasma TNF-alpha in late-pregnancy rats results in significant increases in systemic vascular resistance and arterial pressure (2, 19, 27). Furthermore, the endothelium-dependent vascular relaxation has been shown to be reduced in systemic vessels of late-pregnancy rats that are chronically infused with TNF-alpha (19). However, a fundamental and as-yet unanswered question is whether the hemodynamic effects of elevated TNF-alpha during pregnancy reflect direct effects of the cytokine on the mechanisms of vascular reactivity. Although studies in TNF-alpha -infused pregnant rats have suggested a possible association between the endothelial cell dysfunction and the hypertension (19), it is not clear whether the reduction in endothelium-dependent vascular relaxation is caused by TNF-alpha or whether it is merely a consequence of the hypertension that is developed during chronic TNF-alpha infusion. Also, other cytokines such as interleukin 6 (IL-6), which is activated by TNF-alpha , have been shown to be elevated in the plasma of preeclamptic women (14, 29, 66), which raises the possibility that the chronic vascular effects of TNF-alpha may not be caused directly by TNF-alpha but rather by another cytokine. This made it necessary to investigate the direct effects of TNF-alpha on the mechanisms of vascular reactivity in systemic vessels during late gestation.

The purpose of the present study was to test the hypothesis that TNF-alpha directly impairs endothelium-dependent relaxation and enhances the contraction in systemic vessels of pregnant rats. We used vascular strips isolated from virgin and late-pregnancy rats to investigate 1) whether TNF-alpha enhances the vascular contraction, particularly in vascular strips of pregnant rats; 2) whether TNF-alpha inhibits endothelium-dependent vascular relaxation, particularly in vascular strips of pregnant rats; and 3) whether the TNF-alpha -induced changes in vascular relaxation and contraction involve alterations in the endothelium-dependent NO-cGMP pathway, because normal pregnancy is associated with increased NO production (1, 18, 54, 62, 69).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animals. Female virgin (nonpregnant, 12 wk old, ~200-250 g; n = 18) and time-pregnant (day 12 of gestation, ~350 g; n = 18) Sprague-Dawley rats were purchased from Harlan Sprague-Dawley (Indianapolis, IN). The rats were housed individually in the animal facility and maintained on ad libitum standard rat chow and tap water on a 12:12-h light-dark cycle. On day 14 of gestation or the equivalent in virgin rats, all rats were anesthetized with isoflurane and underwent a surgical procedure for catheter implantation. A small polyethylene 50 (PE-50) catheter was placed in the carotid artery for measurement of arterial pressure. The catheter was filled with heparin and exteriorized at the back of the neck. Rats were then housed individually, allowed to recover, and studied five days later (days 19-20 of pregnancy or the equivalent in virgin rats). All procedures were performed in accordance with the guidelines of the Animal Care and Use Committee at the University of Mississippi Medical Center and the American Physiological Society.

Measurement of mean arterial pressure. On the day of the experiment, each rat was placed in a Plexiglas restrainer. The carotid arterial catheter was connected to a Statham pressure transducer and the mean arterial pressure was continuously recorded in conscious rats on a Grass polygraph (model 7D, Astro-Med, West Warwick, RI). The mean arterial pressure values were 107 ± 4 mmHg in virgin rats and 96 ± 3 mmHg in pregnant rats.

Tissue preparation. The rats were anesthetized by inhalation of isoflurane. The thoracic aorta was rapidly excised, placed in oxygenated Krebs solution, and cleaned of connective tissue. The aorta was cut transversely into 3-mm-wide rings. Aortic rings were cut open into strips. For endothelium-intact vascular strips, extreme care was taken throughout the procedure to avoid injury of the endothelium. For endothelium-denuded vascular strips, the endothelium was removed by gently rubbing the vessel interior with wet filter paper. Removal of the endothelium was routinely verified by the absence of ACh relaxation in vascular strips precontracted with submaximal concentrations of phenylephrine (Phe).

Isometric tension. One end of the vascular strip was attached to a glass hook using a thread loop, and the other end was connected to a Grass force transducer (model FT03, Astro-Med). Vascular strips were stretched to Lmax (1.5× the unloaded initial length, L). To determine Lmax, the vascular strips were stretched to different lengths and then stimulated with 96 mM KCl; the tissue length at which no further increase in KCl response was observed was considered Lmax. Lmax was measured separately in vascular strips of virgin and pregnant rats. Lmax in virgin rats was not significantly different from that in pregnant rats. Vascular strips were allowed to equilibrate for 1 h in a water-jacketed, temperature-controlled tissue bath filled with 50 ml of Krebs solution that was continuously bubbled with 95% O2-5% CO2 at 37°C. The changes in isometric tension were recorded on a Grass polygraph (model 7D).

A control contraction was elicited by applying Phe (10-5 M) to the tissue bath solution. Once the Phe contraction reached a plateau, the tissue was rinsed with Krebs solution three times for 10 min each time. The whole procedure of contraction and washing was repeated twice. The tissues were then either nontreated or were treated with one concentration of TNF-alpha (10-1,000 pg/ml) for 2 h. Increasing concentrations of Phe were applied, the contractile responses were recorded, and concentration-response curves were constructed.

In other experiments, nontreated and TNF-alpha -treated vascular strips were stimulated with Phe to elicit a submaximal contraction. Increasing concentrations of ACh, bradykinin, or sodium nitroprusside were added, and the extent of vascular relaxation was measured. In other experiments, nontreated and TNF-alpha -treated vascular strips were incubated for 30 min in the presence or the absence of NG-nitro-L-arginine methyl ester (L-NAME, 100 µM), to inhibit NOS, or with 1H-[1,2,4]oxadiazolo[4,3]-quinoxalin-1-one (ODQ, 1 µM), to inhibit cGMP production in smooth muscle (32, 52), and the effects on the Phe-induced contraction and the ACh-induced relaxation of Phe contraction were measured. The concentrations of L-NAME and ODQ were selected based on previous studies, which have shown that these inhibitors are effective and specific at the concentrations used in this preparation (26, 52, 58, 64).

Nitrite/nitrate production. Endothelium-intact vascular strips were placed in test tubes containing 1.5 ml Krebs solution with or without TNF-alpha aerated with 95% O2-5% CO2 at 37°C, and the solution was changed every 10 min for 2 h. Samples for basal accumulation of nitrite formed from released NO were first taken. The Krebs solution was replaced, and the strips were stimulated with ACh for 10 min. The vascular strips were rapidly removed, dabbed dry with filter paper, and weighed. The incubation solutions were assayed for the stable end product of NO, NO<UP><SUB>2</SUB><SUP>−</SUP></UP>. Briefly, samples of the incubation solution (50 µl, in triplicate) were mixed in a 96-well microtiter plate with 100 µl of the Griess reagent (26). The chromophore generated by the reaction with nitrite was detected spectrophotometrically (550 nm) using a microtiter plate reader (BioTek, Winooski, VT). The concentration of nitrite was calculated using a reference calibration curve with known concentrations of NaNO2.

Solutions, drugs, and chemicals. Normal Krebs solution contained (in mM) 120 NaCl, 5.9 KCl, 25 NaHCO3, 1.2 NaH2PO4, 11.5 dextrose, 1.2 MgCl2, and 2.5 CaCl2 at pH 7.4. Recombinant rat TNF-alpha was purchased from Biosource International (Camarillo, CA). Stock solutions of L-phenylephrine HCl, ACh, bradykinin, sodium nitroprusside, and L-NAME (Sigma) were prepared in distilled water. ODQ (Calbiochem, La Jolla, CA) was dissolved in DMSO (final concentration <0.1). All other chemicals were of reagent grade or better.

Statistical analysis. The developed force was corrected for the cross-sectional area of each individual strip and was expressed as active stress (N/m2) using the equation stress = force/cross-sectional area, where cross-sectional area = wet weight/(tissue density × length of strip), and tissue density = 1.055 g/cm3 as previously described (35, 59). Data from vascular strips of the same animal were averaged and presented as data from one animal, and n represented the number of animals. Data were analyzed and expressed as means ± SE. Data were compared using ANOVA with multiple classification criteria [rat type (pregnant vs. virgin), condition of endothelium (intact vs. denuded), and treatment (control nontreated vs. TNF-alpha treated, or in presence vs. absence of L-NAME or ODQ)] followed by Bonferroni's post hoc test to compare selected groups. Differences were considered statistically significant if P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In endothelium-intact vascular strips of virgin rats, Phe caused concentration-dependent increases in contraction (Fig. 1A). Application of TNF-alpha on top of Phe contraction did not immediately augment the contraction in the precontracted vascular strips. Treatment of the vascular strips with TNF-alpha (1,000 pg/ml) for 30 min, 1 h, or 2 h did not cause significant changes in tension. Pretreatment of the vascular strips with TNF-alpha (1,000 pg/ml) for 30 min or 1 h did not significantly enhance the Phe contraction. On the other hand, pretreatment of the vascular strips of virgin rats with TNF-alpha (1,000 pg/ml) for 2 h enhanced the Phe contraction (Fig. 1A). The Phe-induced contraction appeared to be smaller in vascular strips of pregnant rats (Fig. 1B) than virgin rats (Fig. 1A). Treatment of the vascular strips with TNF-alpha (1,000 pg/ml) for 2 h enhanced the Phe contraction to a greater extent in pregnant rats (Fig. 1B) compared with virgin rats (Fig. 1A).


View larger version (12K):
[in this window]
[in a new window]
  		Fig. 1.   Representative traces of phenylephrine (Phe)-induced contraction in aortic strips isolated from virgin (A) and pregnant (B) rats, nontreated or treated with tumor necrosis factor-alpha (TNF-alpha ). Endothelium-intact strips incubated in normal Krebs solution were either nontreated or were treated with 1,000 pg/ml TNF-alpha for 2 h and then stimulated with increasing concentrations of Phe. Unlabeled arrow represents a threefold greater concentration than the preceding arrow.

To correct for the difference in the size of the vascular strips, the Phe contraction was normalized for the cross-sectional area of the vascular strip and presented as active stress (Fig. 2). In virgin rats, Phe caused concentration-dependent increases in active stress to a maximum of (5.0 ± 0.3) × 104 N/m2 (Fig. 2A). The Phe-induced active stress was reduced to a maximum of (4.2 ± 0.4) × 10 4 N/m2 in pregnant rats (Fig. 2B). Increasing concentrations of TNF-alpha (10-1,000 pg/ml) caused concentration-dependent enhancement of the Phe-induced active stress in vascular strips of virgin rats (Fig. 2A). The maximum Phe-induced stress in TNF-alpha -treated vascular strips of virgin rats [(7.4 ± 0.5) × 104 N/m2] was significantly greater (P = 0.002) than that in nontreated strips of virgin rats (Fig. 2A). Increasing concentrations of TNF-alpha (10-1,000 pg/ml) caused greater enhancement of Phe-induced stress in vascular strips of pregnant rats (Fig. 2B). The maximum Phe-induced stress in TNF-alpha -treated vascular strips of pregnant rats [(10.5 ± 0.7) × 104 N/m2] was significantly greater (P < 0.001) than that in nontreated strips of pregnant rats (Fig. 2B). TNF-alpha concentrations >1,000 pg/ml did not cause any further enhancement of Phe contraction in virgin or pregnant rats. When the Phe response was presented as a percentage of the maximum Phe contraction, Phe appeared to be more potent in causing contraction in TNF-alpha -treated than -nontreated vessels (Fig. 2, C and D). Analysis of the half-maximally effective dose (ED50) value for Phe indicated that Phe was more potent (P = 0.049) in TNF-alpha -treated than -nontreated vessels of virgin rats and significantly more potent (P = 0.001) in TNF-alpha -treated than -nontreated vessels of pregnant rats (Table 1).


View larger version (30K):
[in this window]
[in a new window]
  		Fig. 2.   Phe-induced contraction in aortic strips of virgin (A, C) and pregnant (B, D) rats nontreated or treated with TNF-alpha . Endothelium-intact strips were either nontreated or treated for 2 h with 10-1,000 pg/ml TNF-alpha and then stimulated with increasing concentrations of Phe. Phe contraction was measured and presented as active stress (A, B) or as % of maximum Phe contraction (C, D). Data points represent means ± SE of measurements in 18-24 vascular strips from 6 virgin and 6 pregnant rats.


                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Maximal Phe-induced active stress and Phe ED50 in vascular strips of virgin and pregnant rats nontreated or treated with TNF-alpha

Removal of the endothelium enhanced the Phe-induced stress slightly in control (nontreated) vascular strips of virgin rats (Fig. 3A). The maximum Phe-induced stress in endothelium-denuded vessels [(6.1 ± 0.5) × 104 N/m2] was not significantly different (P = 0.122) from endothelium-intact vessels of virgin rats [(5.0 ± 0.3) × 104 N/m2]. In contrast, removal of the endothelium significantly enhanced the Phe-induced stress in control (nontreated) vascular strips of pregnant rats (Fig. 3B). The maximum Phe-induced stress was significantly greater (P = 0.003) in endothelium-denuded [(6.7 ± 0.5) × 104 N/m2] than endothelium-intact vessels of pregnant rats [(4.2 ± 0.4) × 104 N/m2]. Removal of the endothelium did not cause any significant increase in Phe-induced stress in TNF-alpha -treated vessels of virgin or pregnant rats (Fig. 3, A and B). When the Phe response was presented as a percentage of the maximum Phe contraction, Phe appeared to be more potent in causing contraction in endothelium-denuded than endothelium-intact vascular strips, particularly those of pregnant rats (Fig. 3, C and D). Analysis of the ED50 value for Phe indicated that the Phe potency was not significantly different (P = 0.392) between endothelium-denuded and endothelium-intact vascular strips of virgin rats, but Phe was significantly more potent (P = 0.005) in endothelium-denuded than endothelium-intact vascular strips of pregnant rats (Table 1). In contrast, the potency of Phe in causing contraction was not significantly different between endothelium-denuded and endothelium-intact TNF-alpha -treated vascular strips of virgin and pregnant rats (Fig. 3, C and D, and Table 1).


View larger version (28K):
[in this window]
[in a new window]
  		Fig. 3.   Effects of endothelium removal on Phe-induced contraction in aortic strips of virgin (A, C) and pregnant (B, D) rats nontreated or treated with TNF-alpha . Endothelium-intact (+Endo) and endothelium-denuded (-Endo) strips were nontreated or treated with 1,000 pg/ml TNF-alpha for 2 h and then stimulated with increasing concentrations of Phe. Phe contraction was measured and presented as active stress (A, B) or as % of maximum Phe contraction (C, D). Data points represent means ± SE of measurements in 12-24 vascular strips from 6 virgin and 6 pregnant rats.

In endothelium-intact vascular strips, incubation with L-NAME (100 µM) for 30 min to inhibit NOS enhanced the Phe-induced stress only slightly in vascular strips of virgin rats (Fig. 4A). The maximal Phe-induced contraction in vascular strips of virgin rats was not significantly different (P = 0.106) in the presence or the absence of L-NAME (see Table 1). Incubation with L-NAME (100 µM) significantly enhanced the Phe-induced stress in vascular strips of pregnant rats (Fig. 4B). The maximal Phe-induced contraction in vascular strips of pregnant rats was significantly greater (P = 0.011) in the presence than absence of L-NAME (see Table 1). Also, plotting of the Phe response as a percentage of maximum response showed that Phe was more potent in causing contraction in the presence than absence of L-NAME, particularly in vascular strips of pregnant rats (Fig. 4, C and D). Analysis of the ED50 value of Phe in virgin rats indicated that the Phe potency was not significantly different (P = 0.496) in the presence or absence of L-NAME (see Table 1). In vascular strips of pregnant rats, Phe was significantly more potent (P = 0.018) in the presence than absence of L-NAME (see Table 1). In contrast, the maximal Phe-induced stress and the ED50 value of Phe in the presence of L-NAME were not significantly different from those in the absence of L-NAME in TNF-alpha -treated vascular strips of virgin or pregnant rats (Fig. 4, Table 1).


View larger version (32K):
[in this window]
[in a new window]
  		Fig. 4.   Effects of L-NAME and 1H-[1,2,4]oxadiazolo[4,3]-quinoxalin-1-one (ODQ) on Phe-induced contraction in aortic strips of virgin (A, C) and pregnant (B, D) rats nontreated or treated with TNF-alpha . Endothelium-intact strips nontreated or treated with 1,000 pg/ml TNF-alpha for 2 h were incubated in the presence or the absence of L-NAME (100 µM) or ODQ (1 µM) for 30 min and then stimulated with increasing concentrations of Phe. Phe contraction was measured and presented as active stress (A, B) or as % of maximum Phe contraction (C, D). Data points represent means ± SE of measurements in 12-24 vascular strips from 6 virgin and 6 pregnant rats.

Similarly, in endothelium-intact strips, incubation with ODQ (1 µM) for 30 min to inhibit cGMP production in smooth muscle (26, 32, 52) enhanced the Phe-induced stress slightly in vascular strips of virgin rats (Fig. 4A). The maximal Phe-induced contraction in vascular strips of virgin rats was not significantly different (P = 0.08) in the presence or absence of ODQ (see Table 1). Incubation with ODQ (1 µM) significantly enhanced the Phe-induced stress in vascular strips of pregnant rats (Fig. 4B). The maximal Phe-induced contraction in vascular strips of pregnant rats was significantly greater (P = 0.002) in the presence than absence of ODQ (see Table 1). Also, Phe was more potent in causing contraction in the presence than absence of ODQ, particularly in vascular strips of pregnant rats (Fig. 4, C and D). Analysis of the ED50 value of Phe in virgin rats indicated that the Phe potency was not significantly different (P = 0.392) in the presence and absence of ODQ (see Table 1). In vascular strips of pregnant rats, Phe was significantly more potent (P = 0.005) in the presence than absence of ODQ (see Table 1). In contrast, the maximal Phe-induced stress and the ED50 value of Phe in the presence of ODQ were not significantly different from those in the absence of ODQ in TNF-alpha -treated vascular strips of virgin and pregnant rats (Fig. 4, Table 1).

In endothelium-intact vascular strips of virgin rats, ACh caused concentration-dependent relaxation of submaximal Phe (3 × 10-7 M)-induced contraction (Fig. 5A). Because the magnitude of Phe contraction was different between vascular strips of virgin and pregnant rats and between TNF-alpha -treated and -nontreated vascular strips, the Phe concentration was adjusted to produce a submaximal contraction that was roughly equal in magnitude to that in virgin rats (Fig. 5). Treatment of vascular strips with TNF-alpha (1,000 pg/ml) for 2 h reduced the ACh relaxation of Phe contraction in vascular strips of virgin rats (see Fig. 1A). The ACh-induced relaxation appeared to be greater in vascular strips of pregnant rats (Fig. 5B) than virgin rats (Fig. 5A). Treatment of the vascular strips with TNF-alpha (1,000 pg/ml) reduced the ACh relaxation of Phe contraction to a greater extent in pregnant rats (Fig. 5B) compared with virgin rats (Fig. 5A).


View larger version (16K):
[in this window]
[in a new window]
  		Fig. 5.   Representative traces of ACh-induced relaxation of Phe contraction in aortic strips of virgin (A) and pregnant (B) rats nontreated or treated with TNF-alpha . Endothelium-intact strips nontreated or treated with TNF-alpha 1,000 pg/ml for 2 h were stimulated with a submaximal concentration of Phe to produce a contraction roughly equal in magnitude in virgin and pregnant rats. Increasing concentrations of ACh were added and the relaxation of Phe contraction was measured. At the end of the experiment, sodium nitroprusside (SNP, 10-6 M) was added to ensure the ability of the smooth muscle to relax.

Cumulative data in vascular strips of virgin rats showed that ACh caused concentration-dependent relaxation of Phe contraction with 10-5 M ACh causing 66.3 ± 2.9% relaxation (Fig. 6A). The ACh-induced relaxation appeared to be enhanced in pregnant rats (Fig. 6B). The ACh (10-5 M)-induced relaxation in pregnant rats (75.2 ± 1.9%) was significantly greater (0.027) than that in virgin rats. Increasing concentrations of TNF-alpha (10-1,000 pg/ml) caused concentration-dependent inhibition of ACh-induced relaxation in virgin rats (Fig. 6A). The ACh (10-5 M)-induced relaxation in vascular strips of virgin rats treated with TNF-alpha (1,000 pg/ml) was significantly reduced to 48.4 ± 5.3% (P = 0.015) compared with nontreated vascular strips of virgin rats. Increasing concentrations of TNF-alpha caused greater inhibition of ACh-induced relaxation in pregnant rats (Fig. 6B). The ACh (10-5 M)-induced relaxation in vascular strips of pregnant rats treated with TNF-alpha (1,000 pg/ml) was significantly reduced to 25.1 ± 2.3% (P < 0.001) compared with nontreated vascular strips of pregnant rats. Higher concentrations of TNF-alpha (3,000 pg/ml) did not cause any further significant inhibition of ACh (10-5 M)-induced relaxation in vascular strips of virgin rats (46.7 ± 4.9%) or pregnant rats (24.6 ± 3.4%).


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 6.   ACh-induced relaxation of Phe contraction in aortic strips of virgin (A) and pregnant (B) rats nontreated or treated with TNF-alpha . Endothelium-intact strips nontreated or treated for 2 h with 10-1,000 pg/ml TNF-alpha were stimulated with Phe to elicit a submaximal contraction. Increasing concentrations of ACh were added and the percent relaxation of Phe contraction was measured. Data points represent means ± SE of measurements in 12-24 vascular strips from 6 virgin and 6 pregnant rats.

Similarly, bradykinin caused concentration-dependent relaxation of Phe contraction to a maximum of 63.4 ± 2.7% in vascular strips of virgin rats and significantly greater (P = 0.03) relaxation in pregnant rats (74.8 ± 3.6%). The maximal bradykinin-induced relaxation in vascular strips of virgin rats treated with TNF-alpha (1,000 pg/ml) was significantly reduced to 46.3 ± 3.5% (P = 0.003) compared with nontreated vascular strips of virgin rats. The maximal bradykinin-induced relaxation in vascular strips of pregnant rats treated with TNF-alpha (1,000 pg/ml) was significantly reduced to 21.7 ± 2.4% (P < 0.001) compared with nontreated vascular strips of pregnant rats.

In endothelium-intact strips, incubation with L-NAME (100 µmol/l) or ODQ (1 µM) for 30 min significantly inhibited the ACh-induced relaxation of Phe contraction in nontreated but to a less extent in TNF-alpha -treated vessels of virgin rats (Fig. 7A). The ACh (10-5 M)-induced relaxation in TNF-alpha -nontreated vessels of virgin rats was significantly reduced in the presence of L-NAME (24.6 ± 7.3%; P < 0.001) or ODQ (30.5 ± 7.0%; P < 0.001) compared with that in the absence of L-NAME or ODQ (66.3 ± 2.9%). The ACh (10-5 M)-induced relaxation in TNF-alpha -treated vessels of virgin rats was reduced to a lesser extent in the presence of L-NAME (17.9 ± 5.9%; P = 0.003) or ODQ (27.89 ± 6.5; P = 0.035) compared to that in the absence of L-NAME or ODQ (48.4 ± 5.3%). In contrast, incubation of endothelium-intact strips in the presence of L-NAME or ODQ markedly and significantly inhibited the ACh-induced relaxation of Phe contraction in nontreated but not TNF-alpha -treated vessels of pregnant rats (Fig. 7B). The ACh (10-5 M)-induced relaxation in TNF-alpha -nontreated vessels of pregnant rats was significantly reduced in the presence of L-NAME (17.7 ± 3.5%; P < 0.001) or ODQ (33.4 ± 5.2%; P < 0.001) compared to that in the absence of L-NAME or ODQ (75.2 ± 1.9%). The ACh (10-5 M)-induced relaxation in TNF-alpha -treated vessels of pregnant rats was not significantly different in the presence of L-NAME (30.5 ± 4.4%; P = 0.307) or ODQ (21.7 ± 2.8; P = 0.374) compared to that in the absence of L-NAME or ODQ (25.1 ± 2.3%). Removal of the endothelium abolished the ACh-induced relaxation in control (nontreated) virgin rats (1.1 ± 0.2%) and pregnant rats (1.5 ± 0.4%) and in TNF-alpha -treated vessels of virgin rats (1.2 ± 0.1%) and pregnant rats (1.3 ± 0.3%).


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 7.   Effects of NG-nitro-L-arginine methyl ester (L-NAME) and ODQ on ACh-induced relaxation in aortic strips of virgin (A) and pregnant (B) rats nontreated or treated with TNF-alpha . Endothelium-intact strips nontreated or treated with 1,000 pg/ml TNF-alpha for 2 h were incubated in the presence or absence of L-NAME (100 µM) or ODQ (1 µM) for 30 min. A submaximal Phe contraction was elicited, increasing concentrations of ACh were added, and the percent relaxation of Phe contraction was measured. Data points represent means ± SE of measurements in 12-24 vascular strips from 6 virgin and 6 pregnant rats.

In endothelium-intact vascular strips of virgin rats, the basal nitrite/nitrate production was 31.6 ± 5.6 pmol/mg tissue weight, and ACh caused concentration-dependent increases in nitrite/nitrate production (Fig. 8A). At 10-5 M concentration, ACh significantly increased (P < 0.001) nitrite/nitrate production to 122 ± 9.1 pmol/mg (Fig. 8A). In vascular strips of pregnant rats (Fig. 8B), the basal (52.1 ± 6.5 pmol/mg) and ACh (10-5 M)-induced nitrite/nitrate production (181 ± 10.9 pmol/mg) were significantly enhanced (P < 0.05) compared with virgin rats (Fig. 8A). TNF-alpha reduced the basal and ACh-induced nitrite/nitrate production slightly in vascular strips of virgin rats (Fig. 8A) but more significantly in pregnant rats (Fig. 8B).


View larger version (18K):
[in this window]
[in a new window]
  		Fig. 8.   Basal and ACh-induced nitrite/nitrate production in endothelium-intact aortic strips of virgin (A) and pregnant (B) rats nontreated or treated with 1,000 pg/ml TNF-alpha for 2 h. Data points represent means ± SE of measurements in 12 vascular strips from 6 virgin and 6 pregnant rats. *P < 0.05, measurements in TNF-alpha -treated strips are significantly different from nontreated strips.

In endothelium-denuded vascular strips, sodium nitroprusside, an exogenous NO donor and a standard guanylate cyclase activator (30), caused concentration-dependent relaxation of submaximal Phe contraction that was not significantly different between nontreated and TNF-alpha -treated vessels of virgin (Fig. 9A) or pregnant (Fig. 9B) rats.


View larger version (16K):
[in this window]
[in a new window]
  		Fig. 9.   Effects of SNP on Phe contraction in aortic strips of virgin (A) and pregnant (B) rats nontreated or treated with TNF-alpha . Endothelium-denuded strips nontreated or treated for 2 h with 100 or 1,000 pg/ml TNF-alpha were stimulated with Phe to induce a submaximal contraction. Increasing concentrations of SNP were added and the percent relaxation of Phe contraction was measured. Data points represent means ± SE of measurements in 12 vascular strips from 6 virgin and 6 pregnant rats.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The main findings of the present study are 1) TNF-alpha enhances the vascular contraction, particularly in vascular strips of pregnant rats; 2) TNF-alpha inhibits endothelium-dependent vascular relaxation, especially in vascular strips of pregnant rats; and 3) the TNF-alpha -induced reduction in vascular relaxation and enhancement of vascular contraction involve alterations in the endothelium-dependent NO-cGMP pathway.

Consistent with previous studies, we have found that the vascular reactivity is reduced in vascular strips of pregnant rats compared with virgin rats (17, 18, 35). An aim of the present study was to investigate whether acute application of TNF-alpha enhances the vascular reactivity in vascular strips of virgin or pregnant rats. Although a previous study (67) has shown that the vascular reactivity to vasoconstrictors is enhanced in TNF-alpha -treated aorta and pulmonary artery of male rats, little information is available on the acute vascular effects of TNF-alpha in females. The present study has shown that TNF-alpha enhances the vascular contraction to the alpha -adrenergic agonist Phe in vascular strips of virgin rats. Also, the enhancement of Phe contraction by acute treatment with TNF-alpha is greater in vascular strips of pregnant compared with virgin rats, which suggests greater enhancement of the mechanisms of vascular contraction in TNF-alpha -treated vessels of pregnant rats.

In the search for possible mechanisms involved in the TNF-alpha -induced enhancement of vascular contraction, we found that removal of the endothelium enhanced the Phe-induced contraction slightly in vascular strips of virgin rats but to a larger extent in vascular strips of pregnant rats. However, removal of the endothelium did not cause a significant increase in Phe-induced contraction in TNF-alpha -treated vessels of virgin or pregnant rats. Also, TNF-alpha caused an inhibition of ACh-induced relaxation that was more prominent in vascular strips of pregnant rats than those of virgin rats. The TNF-alpha -induced inhibition of ACh relaxation did not appear to be due to blockade of endothelial cholinergic receptors, because TNF-alpha caused inhibition of bradykinin-induced relaxation, which was also more prominent in pregnant than virgin rats. These results suggest that TNF-alpha inhibits an endothelium-dependent relaxation pathway particularly in blood vessels of pregnant rats.

One important vasodilator released from endothelial cells is NO (25, 33, 48, 53). Also, significant increases in endothelial NO production have been shown during pregnancy (1, 18, 54, 62, 69). Thus it seems reasonable to assume that the TNF-alpha -induced inhibition of ACh-induced relaxation could be due to a decrease in the synthesis or release of NO from endothelial cells or a change in the sensitivity of vascular smooth muscle to relaxation by NO. The sensitivity of vascular smooth muscle to relaxation by NO could be evaluated by exogenous NO donors such as sodium nitroprusside. The observation that the relaxation of endothelium-denuded vascular strips by sodium nitroprusside was not significantly different between nontreated and TNF-alpha -treated vessels of virgin and pregnant rats provided evidence that TNF-alpha does not affect the sensitivity of vascular smooth muscle to relaxation, and thereby suggests that the reduced ACh-induced relaxation in TNF-alpha -treated vessels of pregnant rats is most likely due to a decrease in the synthesis or release of NO from endothelial cells.

To further investigate the possible role of NO synthesis and release in the observed impaired endothelium-dependent relaxation in the TNF-alpha -treated vessels of pregnant rats, we found that incubation of the vascular strips in the presence of L-NAME, which is known to block NO synthesis, significantly inhibited vascular relaxation by ACh and enhanced the vascular contraction to Phe, particularly in control (nontreated) vascular strips of pregnant rats, but had minimal effects in TNF-alpha -treated vessels. These results suggest that NO synthesis by endothelial cells is intact in control (nontreated) vascular strips of pregnant rats, but is impaired during treatment of the vascular strips with TNF-alpha . This is further supported by the observation that TNF-alpha caused significant reduction in both the basal and the ACh-induced nitrite/nitrate production in vascular strips, particularly those of pregnant rats.

The precise mechanism by which TNF-alpha could inhibit endothelial NO production and/or release is not clear at the present time, but could be related to changes in the endothelial cells, endothelial NOS (eNOS) protein expression, or changes in NOS activity. TNF-alpha has been shown to induce endothelial cell apoptosis (56). Although high levels of TNF-alpha , as observed during septic shock or after administration of a high dose of lipopolysaccharide, activate gene expression of inducible NOS and promote vasodilation, modest levels of TNF-alpha have been shown to downregulate eNOS mRNA by shortening its half-life (5, 72). We have recently found that small-dose infusion of TNF-alpha in pregnant rats is associated with a significant decrease in the expression of renal neuronal NOS isoform; however, no significant change in the amount of eNOS protein could be observed between pregnant rats treated and not treated with TNF-alpha (2). Also, given the relatively short time frame of the present experiments, it seems improbable that the acute vascular effects of TNF-alpha are due to inhibition of eNOS expression. Instead, the acute effects of TNF-alpha are more likely related to one of several potential posttranscriptional and/or posttranslational effects. For example, TNF-alpha -treated endothelial cells could exhibit a tighter association of eNOS with inhibitory molecules such as caveolin-1 (44). Also, TNF-alpha may interfere with the myristoylation and palmitolyation of eNOS and its translocation to and association with plasmalemmal caveolae, a process required for its full activation (44, 57). TNF-alpha may also change the activity of mitogen-activated protein kinase, a signaling pathway that induces eNOS phosphorylation and enzyme inhibition (8). Additionally, pretreatment of bovine aortic endothelial cells with TNF-alpha has been shown to inhibit the phosphatidylinositol-3-kinase-Akt/protein kinase B (PKB) pathway and to prevent PKB-induced phosphorylation and activation of eNOS (36). Furthermore, TNF-alpha could inhibit endothelial NO production via a protein kinase C (PKC)-dependent mechanism. This is supported by reports that TNF-alpha activates endothelial PKC (23) and that PKC can cause eNOS phosphorylation and inhibition of NOS activity (45, 50).

The NO produced by endothelial cells is known to promote vascular relaxation by activating guanylate cyclase and increasing cGMP production in vascular smooth muscle (30, 33). We found that ODQ, which is known to inhibit guanylate cyclase and to decrease cGMP production in smooth muscle (26, 32, 52), inhibited the endothelium-dependent vascular relaxation by ACh and enhanced the vascular contraction to Phe in endothelium-intact strips, particularly those of pregnant rats, but not in TNF-alpha -treated vessels of pregnant rats. These results further support the contention that TNF-alpha decreases NO production and/or release by endothelial cells and thereby the activity of the NO-cGMP pathway in vascular smooth muscle of pregnant rats.

Although the present results suggest that TNF-alpha inhibits an endothelium-dependent NO-cGMP vascular relaxation pathway, several cautionary remarks need to be emphasized regarding these interpretations. First, the vascular endothelium has been shown to release other vasodilator substances in addition to NO, such as endothelium-derived hyperpolarizing factor and prostacyclin (10, 65). This may explain why some relaxation to ACh was still observed in the vascular strips of TNF-alpha -treated vessels that was not completely inhibited by L-NAME or ODQ. The potential role of these additional NO-independent pathways of vascular relaxation is of particular importance in resistance vessels. Second, although the present data suggest that the enhanced vascular contraction in the TNF-alpha -treated vessels of pregnant rats is likely due to inhibition of an endothelium-dependent vascular relaxation pathway, we cannot rule out the possibility that TNF-alpha may increase the release or the sensitivity of vascular smooth muscle to endothelium-derived contracting factors. This is supported by reports that TNF-alpha stimulates the production of endothelium-derived contracting factors such as endothelin-1 (37, 42). Third, TNF-alpha may also enhance the vascular contraction by an additional endothelium-independent mechanism. This is supported by the observation that removal of the endothelium or incubation of endothelium-intact vascular strips of pregnant rats in the presence of L-NAME or ODQ caused an enhancement of Phe-induced contraction to levels that were still less than that in TNF-alpha -treated vessels of pregnant rats. These observations suggest that TNF-alpha may have direct effects on the cellular mechanisms of vascular smooth muscle contraction. This is supported by reports that TNF-alpha may increase the activity of Ca2+-dependent and -independent protein kinases and enhance contraction in smooth muscle (6, 31, 55). The enhanced endothelium-independent TNF-alpha -induced effects in pregnant rat smooth muscle cells suggest that the TNF-alpha -sensitive mechanisms of smooth muscle contraction may be augmented during pregnancy and should represent important areas for future investigations.

An important question is why TNF-alpha caused greater enhancement of vascular contraction and more pronounced inhibition of endothelial NO-cGMP relaxation in blood vessels of pregnant rats compared with those of virgin rats. Although the exact cause of the dramatic effects of TNF-alpha in blood vessels of pregnant rats is not clear at the present time, it could be related in part to the activity of the NO-cGMP pathway. The tissue expression and activity of NOS (4, 13, 61, 68) and the amount of endothelial NO production (1, 18, 54, 62, 69) as well as the metabolic production and plasma level of cGMP (15) have been shown to be increased during pregnancy. Also, TNF-alpha has been shown to downregulate eNOS mRNA (5, 72) and to significantly inhibit NO release from the vascular endothelium, particularly when it is stimulated (28, 71).

The question remains as to how the acute vascular effects of TNF-alpha in pregnant rats relate to human preeclampsia. It has been hypothesized that placental ischemia and hypoxia during late pregnancy may contribute to maternal endothelial cell dysfunction by enhancing the synthesis of cytokines such as TNF-alpha (12, 14). In support of the cytokine hypothesis, several studies have shown increased plasma levels of TNF-alpha during preeclampsia (14, 39, 66, 70). However, some studies have shown no change in plasma TNF-alpha levels in preeclamptic women (22, 29). Also, although several studies have shown that TNF-alpha levels are elevated in the maternal venous circulation (14, 39, 66, 70), some studies have reported a decrease in TNF-alpha in the umbilical cord plasma of patients with severe preeclampsia (38). It has also been reported that plasma TNF-alpha is elevated in 36% of cases of established preeclampsia, but the rise in plasma TNF-alpha levels occurs only after the syndrome is detected clinically and is not related to the severity of the disease (43), which suggests that circulating TNF-alpha may not contribute to the development of preeclampsia but may rise as a consequence of the pathological processes of the disease.

Nevertheless, reports that the plasma levels of TNF-alpha are elevated approximately twofold in women with preeclampsia (14, 39, 66, 70) and that chronic infusion of TNF-alpha in pregnant rats causes endothelial cell dysfunction and increases the vascular resistance and arterial pressure (2, 19, 27) still support a possible role of TNF-alpha in pregnancy-induced hypertension. Although the present results suggest that the direct TNF-alpha -induced inhibition of endothelial vascular relaxation and enhancement of vascular contraction may contribute to the increased vascular resistance and arterial pressure in pregnant rats chronically infused with TNF-alpha , the relationship between the acute effects of TNF-alpha in vascular strips of pregnant rats in vitro and the hemodynamic effects during pregnancy in vivo should be interpreted with caution. Clinical studies in humans have suggested that the plasma levels of TNF-alpha vary between 0.5 and 100 pg/ml (9, 22, 60). In the present study, TNF-alpha concentrations of 30-1,000 pg/ml were required to produce significant effects, particularly in the vasculature of pregnant rats. Whether TNF-alpha concentrations similar to those observed in human plasma induce significant effects in the human vasculature remains to be investigated. The present results also suggest that the Phe-induced contraction of aortic strips of pregnant rats is enhanced by TNF-alpha . On the other hand, preeclampsia is associated with increased plasma levels of endothelin 1 and increased pressor responses to ANG II (40, 63). Whether acute treatment with TNF-alpha enhances the vascular contraction to other vasoconstrictors such as endothelin 1 and ANG II and in small resistance vessels with more relevance to preeclampsia is unclear and should represent important areas for future investigation. Also, TNF-alpha may have additional vascular or nonvascular effects during pregnancy in vivo. For example, TNF-alpha may activate other vasoactive factors during pregnancy in vivo. This is supported by reports that IL-6, which is activated by TNF-alpha , is also elevated approximately twofold in the plasma of women with preeclampsia (14, 29, 66). Whether acute exposure to IL-6 enhances the vascular contraction is unclear and should be investigated in future studies. TNF-alpha may also increase the arterial pressure in late pregnancy via additional renal mechanisms that involve decreased renal plasma flow and glomerular filtration rate (27).

In conclusion, TNF-alpha inhibits an endothelium-dependent NO-cGMP-mediated vascular relaxation pathway in systemic vessels, particularly those of pregnant rats. The greater TNF-alpha -induced inhibition of vascular relaxation and enhancement of vascular contraction in systemic vessels of pregnant rats supports a direct role for TNF-alpha as one possible mediator of the increased vascular resistance that is associated with pregnancy-induced hypertension.


    ACKNOWLEDGEMENTS

This work was supported by Grants HL-33849, HL-51971, HL-52696, and HL-65998 from the National Heart, Lung, and Blood Institute and a Grant-in-Aid from the American Heart Association, Mississippi Affiliate. R. A. Khalil is an Established Investigator of the American Heart Association.


    FOOTNOTES

Address for reprint requests and other correspondence: R. A. Khalil, Dept. of Physiology and Biophysics, Univ. of Mississippi Medical Center, 2500 North State St., Jackson, MS 39216-4505 (E-mail: rkhalil{at}physiology.umsmed.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published February 28, 2002;10.1152/ajpregu.00704.2001

Received 27 November 2001; accepted in final form 25 February 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ahokas, RA, Mercer BM, and Sibai BM. Enhanced endothelium-derived relaxing factor activity in pregnant, spontaneously hypertensive rats. Am J Obstet Gynecol 165: 801-807, 1991[Web of Science][Medline].

2.   Alexander, BT, Cockrell KL, Massey MB, Bennett WA, and Granger JP. Tumor necrosis factor-alpha -induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 15: 112-119, 2002.

3.   Alexander, BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, and Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191-1195, 2001[Abstract/Free Full Text].

4.   Alexander, BT, Miller MT, Kassab S, Novak J, Reckelhoff JF, Kruckeberg WC, and Granger JP. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33: 435-439, 1999[Abstract/Free Full Text].

5.   Alonso, J, Sanchez de Miguel L, Monton M, Casado S, and Lopez-Farre A. Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor-alpha . Mol Cell Biol 17: 5719-5726, 1997[Abstract].

6.   Amrani, Y, Martinet N, and Bronner C. Potentiation by tumour necrosis factor-alpha of calcium signals induced by bradykinin and carbachol in human tracheal smooth muscle cells. Br J Pharmacol 114: 4-5, 1995[Web of Science][Medline].

7.   Baylis, C, Suto T, and Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat and implications for preeclampsia. Hypertens Pregnancy 15: 147-169, 1996[Web of Science].

8.   Bernier, SG, Haldar S, and Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 275: 30707-30715, 2000[Abstract/Free Full Text].

9.   Bertolaccini, ML, Atsumi T, Lanchbury JS, Caliz AR, Katsumata K, Vaughan RW, Kondeatis E, Khamashta MA, Koike T, and Hughes GR. Plasma tumor necrosis factor-alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 85: 198-203, 2001[Web of Science][Medline].

10.   Brandes, RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, and Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000[Abstract/Free Full Text].

11.   Conrad, KP. Animal models of pre-eclampsia: do they exist? Fetal Med Rev 2: 67-88, 1990.

12.   Conrad, KP, and Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37: 240-249, 1997[Web of Science][Medline].

13.   Conrad, KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, and Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7: 566-571, 1993[Abstract].

14.   Conrad, KP, Miles TM, and Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40: 102-111, 1998[Web of Science][Medline].

15.   Conrad, KP, and Vernier KA. Plasma levels, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol Regulatory Integrative Comp Physiol 257: R847-R853, 1989[Abstract/Free Full Text].

16.   Crews, JK, Herrington JN, Granger JP, and Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35: 367-372, 2000[Abstract/Free Full Text].

17.   Crews, JK, Novak J, Granger JP, and Khalil RA. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol Regulatory Integrative Comp Physiol 276: R530-R538, 1999[Abstract/Free Full Text].

18.   Davidge, ST, and McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167: 1691-1698, 1992[Web of Science][Medline].

19.   Davis, JR, Giardina JB, Green GM, Alexander BT, Granger JP, and Khalil RA. Decreased endothelium-dependent vascular relaxation via the NO-cGMP pathway during TNF-alpha -induced hypertension in pregnant rats. Am J Physiol Regulatory Integrative Comp Physiol 282: R390-R399, 2002[Abstract/Free Full Text].

20.   Duvekot, JJ, and Peeters LL. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv 49: 830-839, 1994[Medline].

21.   Eder, DJ, and McDonald MT. A role for brain angiotensin II in experimental pregnancy-induced hypertension in laboratory rats. Clin Exp Hypertens B 6: 431-451, 1987[Web of Science].

22.   Ellis, J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, Wennergren M, and Hagberg H. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80: 602-608, 2001[Web of Science][Medline].

23.   Ferro, TJ, Parker DM, Commins LM, Phillips PG, and Johnson A. Tumor necrosis factor-alpha activates pulmonary artery endothelial protein kinase C. Am J Physiol Lung Cell Mol Physiol 264: L7-L14, 1993[Abstract/Free Full Text].

24.   Friedman, SA, Lubarsky SL, Ahokas RA, Nova A, and Sibai BM. Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide. Clin Perinatol 22: 343-355, 1995[Web of Science][Medline].

25.   Furchgott, RF, and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980[Medline].

26.   Giardina, JB, Green GM, Rinewalt AN, Granger JP, and Khalil RA. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet. Hypertension 37: 516-523, 2001[Abstract/Free Full Text].

27.   Granger, JP, Bennett WA, Alexander BT, Cockrell KL, and Whitwhorth NS. Long-term elevation of plasma TNF-alpha increases arterial pressure and reduces kidney function in pregnant rats (Abstract). Hypertension 34: 337, 1999.

28.   Greenberg, S, Xie J, Wang Y, Cai B, Kolls J, Nelson S, Hyman A, Summer WR, and Lippton H. Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J Appl Physiol 74: 2394-2403, 1993[Abstract/Free Full Text].

29.   Greer, IA, Lyall F, Perera T, Boswell F, and Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 84: 937-940, 1994[Web of Science][Medline].

30.   Gruetter, CA, Gruetter DY, Lyon JE, Kadowitz PJ, and Ignarro LJ. Relationship between cyclic guanosine 3',5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219: 181-186, 1981[Abstract/Free Full Text].

31.   Hsu, YM, Chiu CT, Wang CC, Chien CS, Luo SF, Hsiao LD, Liang KY, and Yang CM. Tumour necrosis factor-alpha enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells. Cell Signal 13: 633-643, 2001[Web of Science][Medline].

32.   Hussain, AS, Marks GS, Brien JF, and Nakatsu K. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha ]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 75: 1034-1037, 1997[Web of Science][Medline].

33.   Ignarro, LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21, 1989[Free Full Text].

34.   Ignarro, LJ, and Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25: 171-191, 1985[Web of Science][Medline].

35.   Khalil, RA, Crews JK, Novak J, Kassab S, and Granger JP. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31: 1065-1069, 1998[Abstract/Free Full Text].

36.   Kim, F, Gallis B, and Corson MA. TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 280: C1057-C1065, 2001[Abstract/Free Full Text].

37.   Klemm, P, Warner TD, Hohlfeld T, Corder R, and Vane JR. Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci USA 92: 2691-2695, 1995[Abstract/Free Full Text].

38.   Kupferminc, MJ, Peaceman AM, Dollberg S, and Socol ML. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia. Am J Perinatol 16: 203-208, 1999[Web of Science][Medline].

39.   Kupferminc, MJ, Peaceman AM, Wigton TR, Rehnberg KA, and Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 170: 1752-1759, 1994[Web of Science][Medline].

40.   Lindheimer, MD, and Katz AI. Renal physiology and disease in pregnancy. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW, and Giebisch G.. New York: Raven, 1992, p. 3371-3431.

41.   Losonczy, G, Brown G, and Venuto RC. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am J Med Sci 303: 233-240, 1992[Web of Science][Medline].

42.   Marsden, PA, and Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha . Am J Physiol Cell Physiol 262: C854-C861, 1992[Abstract/Free Full Text].

43.   Meekins, JW, McLaughlin PJ, West DC, McFadyen IR, and Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha ) and the development of pre-eclampsia. Clin Exp Immunol 98: 110-114, 1994[Web of Science][Medline].

44.   Michel, T. Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res 32: 1361-1366, 1999[Web of Science][Medline].

45.   Michell, BJ, Chen Zp, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, and Kemp BE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276: 17625-17628, 2001[Abstract/Free Full Text].

46.   Molnar, M, and Hertelendy F. Nomega -nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 166: 1560-1567, 1992[Web of Science][Medline].

47.   Molnar, M, Suto T, Toth T, and Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170: 1458-1466, 1994[Web of Science][Medline].

48.   Moncada, S, Palmer RM, and Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12: 365-372, 1988[Abstract/Free Full Text].

49.   Morris, NH, Eaton BM, and Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 103: 4-15, 1996[Web of Science][Medline].

50.   Murthy, KS, Jin JG, and Makhlouf GM. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C. Am J Physiol Gastrointest Liver Physiol 266: G161-G165, 1994[Abstract/Free Full Text].

51.   Nathan, L, Cuevas J, and Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 114: 955-960, 1995[Web of Science][Medline].

52.   Olson, LJ, Knych ET, Jr, Herzig TC, and Drewett JG. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension 29: 254-261, 1997[Abstract/Free Full Text].

53.   Palmer, RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987[Medline].

54.   Parent, A, Schiffrin EL, and St. Louis J. Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats. Am J Obstet Gynecol 163: 229-234, 1990[Web of Science][Medline].

55.   Parris, JR, Cobban HJ, Littlejohn AF, MacEwan DJ, and Nixon GF. Tumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle. J Physiol 518: 561-569, 1999[Abstract/Free Full Text].

56.   Petrache, I, Verin AD, Crow MT, Birukova A, Liu F, and Garcia JG. Differential effect of MLC kinase in TNF-alpha -induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280: L1168-L1178, 2001[Abstract/Free Full Text].

57.   Prabhakar, P, Cheng V, and Michel T. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae. J Biol Chem 275: 19416-19421, 2000[Abstract/Free Full Text].

58.   Rees, DD, Palmer RM, Schulz R, Hodson HF, and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990[Web of Science][Medline].

59.   Rembold, CM, and Murphy RA. Myoplasmic [Ca2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle. Circ Res 63: 593-603, 1988[Abstract/Free Full Text].

60.   Sheu, WH, Lee WJ, Lin LY, Chang RL, and Chen YT. Tumor necrosis factor-alpha -238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism 50: 1447-1451, 2001[Web of Science][Medline].

61.   Singh, R, Pervin S, Rogers NE, Ignarro LJ, and Chaudhuri G. Evidence for the presence of an unusual nitric oxide- and citrulline-producing enzyme in rat kidney. Biochem Biophys Res Commun 232: 672-677, 1997[Web of Science][Medline].

62.   Sladek, SM, Magness RR, and Conrad KP. Nitric oxide and pregnancy. Am J Physiol Regulatory Integrative Comp Physiol 272: R441-R463, 1997[Abstract/Free Full Text].

63.   Taylor, RN, Varma M, Teng NN, and Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71: 1675-1677, 1990[Abstract/Free Full Text].

64.   Tseng, CM, Tabrizi-Fard MA, and Fung HL. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J Pharmacol Exp Ther 292: 737-742, 2000[Abstract/Free Full Text].

65.   Vanhoutte, PM. Vascular biology. Old-timer makes a comeback. Nature 396: 213-216, 1998[Medline].

66.   Vince, GS, Starkey PM, Austgulen R, Kwiatkowski D, and Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102: 20-25, 1995[Web of Science][Medline].

67.   Wang, P, Ba ZF, and Chaudry IH. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 266: H2535-H2541, 1994[Abstract/Free Full Text].

68.   Weiner, CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, and Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91: 5212-5216, 1994[Abstract/Free Full Text].

69.   Williams, DJ, Vallance PJ, Neild GH, Spencer JA, and Imms FJ. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol Heart Circ Physiol 272: H748-H752, 1997[Abstract/Free Full Text].

70.   Williams, MA, Mahomed K, Farrand A, Woelk GB, Mudzamiri S, Madzime S, King IB, and McDonald GB. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic, and normotensive pregnant Zimbabwean women. J Reprod Immunol 40: 159-173, 1998[Web of Science][Medline].

71.   Xie, J, Wang Y, Lippton H, Cai B, Nelson S, Kolls J, Summer WR, and Greenberg SS. Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide. Am Rev Respir Dis 148: 627-636, 1993[Web of Science][Medline].

72.   Yoshizumi, M, Perrella MA, Burnett JC, Jr, and Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209, 1993[Abstract].

Am J Physiol Regul Integr Comp Physiol 283(1):R130-R143
0363-6119/02 $5.00 Copyright © 2002 the American Physiological Society


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Granger
An emerging role for inflammatory cytokines in hypertension
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H923 - H924.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Inflammatory cytokines, vascular function, and hypertension
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R989 - R990.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Orshal and R. A. Khalil
Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/R130    most recent
00704.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giardina, J. B.
Right arrow Articles by Khalil, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giardina, J. B.
Right arrow Articles by Khalil, R. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online